z-logo
open-access-imgOpen Access
Maraviroc: a therapeutic innovation for the AIDS management
Author(s) -
Amanda Silva de Miranda,
Carolina M. Avila,
Fernanda C. da Silva,
Raquel de Oliveira Lopes
Publication year - 2010
Publication title -
revista virtual de química
Language(s) - Portuguese
Resource type - Journals
SCImago Journal Rank - 0.209
H-Index - 14
ISSN - 1984-6835
DOI - 10.5935/1984-6835.20100012
Subject(s) - maraviroc , medicine , business , knowledge management , human immunodeficiency virus (hiv) , computer science , virology
Este trabalho descreve, brevemente, o processo de desenvolvimento do maraviroque, o primeiro fármaco de uma nova classe de antirretrovirais: os antagonistas de CCR5. Esse fármaco foi aprovado pela FDA em 2007 para utilização no tratamento da AIDS.  DOI: 10.5935/1984-6835.20100012This paper briefly describes the development of maraviroc, the first drug of a new antiretroviral class: the CCR5 antagonists. This drug was approved by FDA for the treatment of AIDS in 2007.  DOI: 10.5935/1984-6835.2010001

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom